Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The aim of our study is to define the optimal ovarian stimulation protocol concerning PGD and
for this reason we plan a randomized controlled trial (RCT) comparing gonadotropin-releasing
hormone (GnRH) agonist protocol versus GnRH antagonist protocol. The follicle stimulating
hormone (FSH) preparation in both arms will be highly purified FSH (Menopur®).